Genetic polymorphism of S-mephenytoin 4'-hydroxylation in African-Americans

被引：43

作者：

Edeki, TI

Goldstein, JA

deMorais, SMF

Hajiloo, L

Butler, M

Chapdelaine, P

Wilkinson, GR

机构：

[1] MEHARRY MED COLL,DEPT PHARMACOL,CLIN PHARMACOL SECT,NASHVILLE,TN 37208

[2] MEHARRY MED COLL,DEPT FAMILY & PREVENT MED,CLIN PHARMACOL SECT,NASHVILLE,TN 37208

[3] NIEHS,RES TRIANGLE PK,NC 27709

[4] VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37232

来源：

PHARMACOGENETICS | 1996年 / 6卷 / 04期

关键词：

mephenytoin; African-American; genetic polymorphism; CYP2C19;

D O I：

10.1097/00008571-199608000-00009

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：357 / 360

页数：4

共 28 条

[1]

ADEDOYIN A, 1994, PHARMACOGENETICS, V4, P27

[2] POLYMORPHIC HYDROXYLATION OF S-MEPHENYTOIN AND OMEPRAZOLE METABOLISM IN CAUCASIAN AND CHINESE SUBJECTS [J].

ANDERSSON, T ;

REGARDH, CG ;

LOU, YC ;

ZHANG, Y ;

DAHL, ML ;

BERTILSSON, L .

PHARMACOGENETICS, 1992, 2 (01) :25-31

[3] IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE [J].

BERTILSSON, L ;

HENTHORN, TK ;

SANZ, E ;

TYBRING, G ;

SAWE, J ;

VILLEN, T .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) :348-355

[4] A MULTIFAMILY STUDY ON THE RELATIONSHIP BETWEEN CYP2C19 GENOTYPE AND S-MEPHENYTOIN OXIDATION PHENOTYPE [J].

BROSEN, K ;

DEMORAIS, SMF ;

MEYER, UA ;

GOLDSTEIN, JA .

PHARMACOGENETICS, 1995, 5 (05) :312-317

[5]

DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594

[6]

DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419

[7] GENETIC-ANALYSIS OF THE S-MEPHENYTOIN POLYMORPHISM IN A CHINESE POPULATION [J].

DEMORAIS, SMF ;

GOLDSTEIN, JA ;

XIE, HG ;

HUANG, SL ;

LU, YQ ;

XIA, H ;

XIAO, ZS ;

ILE, N ;

ZHOU, HH .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (04) :404-411

[8] FREQUENCY OF IMPAIRED MEPHENYTOIN 4'-HYDROXYLATION IN AN INDIAN POPULATION [J].

DOSHI, BS ;

KULKARNI, RD ;

CHAUHAN, BL ;

WILKINSON, GR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (05) :779-780

[9] EVIDENCE THAT CYP2C19 IS THE MAJOR (S)-MEPHENYTOIN 4'-HYDROXYLASE IN HUMANS [J].

GOLDSTEIN, JA ;

FALETTO, MB ;

ROMKESSPARKS, M ;

SULLIVAN, T ;

KITAREEWAN, S ;

RAUCY, JL ;

LASKER, JM ;

GHANAYEM, BI .

BIOCHEMISTRY, 1994, 33 (07) :1743-1752

[10] DIAZEPAM DISPOSITION DETERMINANTS [J].

GREENBLATT, DJ ;

ALLEN, MD ;

HARMATZ, JS ;

SHADER, RI .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) :301-312

← 1 2 3 →